Sanofi - M&A Summary and Business Overview

Life ScienceCompany

Sanofi M&A Summary

Sanofi has acquired 31 companies, including 8 in the last 5 years. A total of 10 acquisitions came from private equity firms. It has also divested 14 assets.

Sanofi’s largest acquisition to date was in 2011, when it acquired Genzyme for $20.1B. It’s largest disclosed sale occurred in 2018, when it sold Zentiva Group a.s. to Advent International for $2.2B. Sanofi has acquired in 8 different US states, and 11 countries. The Company’s most targeted sectors include life science (67%) and medical products (15%).

Sanofi Business Overview

Where is Sanofi headquartered?

Sanofi is headquartered in Paris, France.

What is Sanofi’s revenue?

Sanofi disclosed revenue of 45,389M EUR for 2022 and 39,175M EUR for 2021.

How many employees does Sanofi have?

Sanofi has 99,412 employees.

What sector is Sanofi in?

Sanofi is a life science company.

When was Sanofi founded?

Sanofi was founded in 1994.

M&A Summary

  • M&A Total Activity41
    • M&A Buy Activity27
    • M&A Sell Activity14
  • Total Sectors Invested 5
  • Total Countries Invested 11
  • M&A Buy/Sell Connections 27
  • M&A Advisors 6

Sanofi

Sanofi SA

54, Rue La Boetie,
Paris, 75008
France,
+33 1 53 77 40 00
www.sanofi.com

Sanofi is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi was founded in 1994 and is based in Paris, France.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.4/yr) # 20 2 4 - - 1 27
vol $40.7B $3.7B $4.7B $49.0B
Sell (0.6/yr) # 11 3 - - - - 14
vol $3.0B $3.0B
  41

Most Recent M&A

Company Date Value Type
Graviton Bioscience Corp. 2024-02-01 - Add-on Acquisition
New York, New York · www.gravitoncorp.com
Amunix Pharmaceuticals, Inc. 2021-12-21 - Add-on Acquisition
South San Francisco, California · www.amunix.com
Translate Bio, Inc. 2021-08-03 3.2B USD Add-on Acquisition
Lexington, Massachusetts · www.translate.bio
Kiadis Pharma BV 2021-05-26 - Going Private
Amsterdam, Netherlands · www.kiadis.com
Kymab 2021-01-11 1.5B USD Add-on Acquisition
Cambridge, United Kingdom · www.kymab.com
Principia Biopharma, Inc. 2020-08-17 3.7B USD Add-on Acquisition
South San Francisco, California · www.principiabio.com
Sanofi SA - OTC Self-Care Brands 2020-08-11 - Divestiture
Paris, France
Sanofi SA - Dellegra 2020-08-04 - Divestiture
Paris, France
Chattem, Inc. 2020-03-20 - Divestiture
Chattanooga, Tennessee · www.kaopectate.com
Synthorx, Inc. 2020-01-23 - Add-on Acquisition
La Jolla, California · www.synthorx.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Genzyme Corp. 2011-02-16 Caprelsa 2015-07-27 1
Cambridge, Massachusetts · www.genzyme.com , United Kingdom · www.caprelsarems.com
Merial Ltd. 2009-07-30 Dosch - Animal Health Division 2012-12-20 1
Duluth, Georgia · www.merial.us , India

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 18 (67%) 41.7B (85%) 8 (57%) 2.7B (88%)
Medical Products 4 (15%) 4.0B (8%) 2 (14%) 350M (12%)
Consumer Products 3 (11%) 2.3B (5%) 3 (21%) -
Business Services 1 (4%) 563M (1%) - -
Healthcare Services 1 (4%) 417M (1%) - -
Chemicals - - 1 (7%) -
Total 27 $49.0B 14 $3.0B

By Geo

State/Country Buy Value Sell Value
United States 16 46.2B 3 775M
  California 5 4.8B - -
  Massachusetts 4 34.9B - -
  New York 2 563M - -
  Tennessee 1 1.9B 1 -
  Pennsylvania 1 - - -
  Georgia 1 4.0B - -
  Florida 1 - - -
  New Jersey - - 1 425M
France 2 417M 9 94M
Czech Republic 1 - 1 2.2B
Australia 1 399M - -
Belgium 1 - - -
Brazil 1 563M - -
Colombia 1 - - -
India 1 - - -
Netherlands 1 - - -
Senegal - - 1 -
Switzerland 1 - - -
United Kingdom 1 1.5B - -
Domestic 2 (7%) 417M (1%) 9 (64%) 94M (3%)
Cross-border 25 (93%) 48.6B (99%) 5 (36%) 2.9B (97%)
Total 27 $49.0B 14 $3.0B

Top M&A Advisors

Financial Deals
Morgan Stanley
2
Evercore Group
2
Lazard Ltd.
1
Legal Deals
Weil Gotshal & Manges
7
Jones Day
1

Deal Values

buy # Total
> $1B 7 $45.9B
$100M to $1B 6 $3.1B
TOTAL $49.0B
Largest Genzyme Corp.
$20.1B (2011-02-16)
sell # Total
> $1B 1 $2.2B
$100M to $1B 2 $775M
< $100M 1 $94M
TOTAL $3.0B
Largest Zentiva Group a.s.
$2.2B (2018-04-17)

M&A Connections

Deals
Acquired from
Investor(s)
22%
6 (22%)
Strategic(s)
11%
3 (11%)
Divested to
Investor(s)
7%
1 (7%)
Strategic(s)
93%
13 (93%)

 Subscribe to unlock this and 202,656
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Sanofi

Life Science Companies , France Companies